Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Voyager Therapeutics
75 Sidney St.
Cambridge, MA 02139
Phone: 857-259-5340
www.voyagertherapeutics.com

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. The company's initial pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson's disease, a monogenic form of amyotrophic lateral sclerosis (ALS), and Friedreich's ataxia. Founded by scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience, Voyager Therapeutics was launched in 2014 with funding from leading life sciences investor Third Rock Ventures and is headquartered in Cambridge, Mass.

Key Contact
Name
Steven Paul
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
02/12/14 $45,000,000 Series A Third Rock Ventures
undisclosed
02/11/15 $30,000,000 Strategic Sanofi
undisclosed


Featured Reading